Medical assistance coverage of prescription drugs clarified in cases of cost-effective health insurance coverage.

HF 667 clarifies when Minnesota's medical assistance program must cover prescription drug costs for individuals with commercial insurance. It requires coverage of copays/coinsurance for drugs approved by a commercial insurer, even if the quantity exceeds a 34-day supply or the drug isn't on the insurer's preferred list, without needing prior approval from the commissioner. This applies specifically when the commercial insurance coverage is deemed "cost-effective" by the commissioner. The bill removes administrative barriers for providers and beneficiaries in these scenarios, streamlining access to covered medications.